Assembly Homepage Heroslider banner

Assembly Homepage Heroslider banner

Assembly Homepage Heroslider banner

ADVANCING NEW CLASSES OF ORAL THERAPEUTICS

HBV

Focused on increasing cure rates for patients with chronic HBV

Microbiome

A best-in-class program with a fully integrated delivery platform

Assembly Biosciences is advancing a new class of oral therapeutics for the treatment of hepatitis B (HBV) infection and novel oral biotherapeutics for disorders associated with the microbiome.

Background Image

News

Background Image

lab Image